Cystatin C, serum creatinine, and estimates of kidney function: Searching for better measures of kidney function and cardiovascular risk

Annals of Internal Medicine

Volumn 142, Issue 7, 2005, Pages 586-588

  Levin, Adeera ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; CYSTATIN C; BIOLOGICAL MARKER; CYSTATIN;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CREATININE BLOOD LEVEL; DEATH; DIET; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MARKER; EDITORIAL; HEART FAILURE; HEMOCONCENTRATION; HUMAN; KIDNEY DISEASE; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; KIDNEY FUNCTION TEST; KIDNEY INJURY; LABORATORY; MEASUREMENT; MORBIDITY; MORTALITY; OUTCOMES RESEARCH; PATHOGENESIS; POPULATION RESEARCH; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY ANALYSIS; STANDARD; BLOOD; CONGESTIVE HEART FAILURE; GLOMERULUS FILTRATION RATE; METHODOLOGY; NOTE;

BIOLOGICAL MARKERS; CREATININE; CYSTATINS; GLOMERULAR FILTRATION RATE; HEART FAILURE, CONGESTIVE; HUMANS; KIDNEY FUNCTION TESTS; RISK FACTORS;

EID: 15944399792     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-142-7-200504050-00016     Document Type: Editorial

References (23)

1. Anavekar NS, McMurray JJ, Velazquez EJ, Solomon SD, Kober L, Rouleau JL, et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med. 2004;351:1285-95.
2. Go AS, Chercow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalizarion. N Engl J Med. 2004;351:1296-305.
3. Muntner P, Hamm LL, Kusek JW, Chen J, Whelton PK, He J. The prevalence of nontraditional risk factors for coronary heart disease in patients with chronic kidney disease. Ann Intern Med. 2004;140:9-17.
4. Weber JA, van Zanten AP. Interferences in current methods for measurements of creatinine. Clin Chem. 1991;37:695-700.
5. Letellier G, Desjarlais F. Analytical interference of drugs in clinical chemistry: II - The interference of three cephalosporins with the determination of serum creatinine concentration by the Jaffé reaction. Clin Biochem. 1985;18:352-6.
6. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31-41.
7. Levey AS, Greene T, Kusek JW, Beck GJ. A simplified equation to predict glomerular filtration rate from serum creatinine [Abstract]. J Am Soc Nephrol. 2000;11:155A.
8. Coll E, Botey A, Alvarez L, Poch E, Quinto L, Saurina A, et al. Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment. Am J Kidney Dis. 2000;36:29-34.
9. Newman DJ, Thakkar H, Edwards RG, Wilkie M, White T, Grubb AO, et al. Serum cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine. Kidney Int. 1995;47:312-8.
10. Gökku̧u CA, Ozden TA, Gül H, Yildiz A. Relationship between plasma Cystatin C and creatinine in chronic renal diseases and Tx-transplant patients. Clin Biochem. 2004;37:94-7.
11. Herget-Rosenthal S, Marggraf G, Hüsing J, Göring F, Pietruck F, Janssen O, et al. Early detection of acute renal failure by serum cystatin C. Kidney Int. 2004;66:1115-22.
12. Liu J, Sukhova GK, Sun JS, Xu WH, Libby P, Shi GP. Lysosomal cysteine proteases in atherosclerosis. Artetiosclet Thtomb Vasc Biol. 2004;24:1359-66.
13. Mares J, Stejskal D, Vavrousková J, Urbánek K, Herzig R, Hlusták P. Use of cystatin C determination in clinical diagnostics. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2003;147:177-80.
14. Knight EL, Verhave JC, Spiegelman D, Hillege HL, de Zeeuw D, Curhan GC, et al. Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int. 2004;65:1416-21.
15. Wasen E, Isoaho R, Mattila K, Vahlberg T, Kivela SL, Irjala K. Serum cystatin C in the aged: relationships with health status. Am J Kidney Dis. 2003;42:36-43.
16. Hojs R, Bevc S, Antolinc B, Gorenjak M, Puklavec L. Serum cystatin C as an endogenous marker of renal function in the elderly. Int J Clin Pharmacol Res. 2004;24:49-54.
17. Mussap M, Dalla Vestra M, Fioretto P, Saller A, Varagnolo M, Nosadini R, et al. Cystatin C is a more sensitive marker than creatinine for the estimation of GFR in type 2 diabetic patients. Kidney Int. 2002;61:1453-61.
18. Van Den Noortgate NJ, Janssens WH, Delanghe JR, Afschrift MB, Lameire NH. Serum cystatin C concenttation compared with other markers of glomerular filtration rate in the old old. J Am Geriatr Soc. 2002;50:1278-82.
19. Burkhardt H, Bojarsky G, Gretz N, Gladisch R. Creatinine clearance, Cockcrofi-Gault formula and cystatin C: estimators of true glomerular filtration rate in the elderly? Gerontology. 2002;48:140-6.
20. Oddoze C, Morange S, Portugal H, Berland Y, Dussol B. Cystatin C is not mote sensitive than creatinine for detecting early renal impairment in patients with diabetes. Am J Kidney Dis. 2001;38:310-6.
21. Sarnak MJ, Katz R, Stehman-Breen CO, Fried LF, Swords Jenny N, Psaty BM, et al. Cystatin C concentration as a risk factor for heart failure in older adults. Ann Intern Med. 2005;142:497-505.
22. Koenig W, Twardella D, Brenner H, Rothenbacher D. Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events: more than simply a marker of glomerular filtration rate. Clin Chem. 2005;51:321-7.
23. Jernberg T, Lindahl B, James S, Larsson A, Hansson LO, Wallentin L. Cystatin C: a novel predictor of outcome in suspected or confirmed non-ST-elevation acute coronary syndrome. Circulation. 2004;110:2342-8.